US3420237A - Process and article for the treatment of severe epistaxis - Google Patents
Process and article for the treatment of severe epistaxis Download PDFInfo
- Publication number
- US3420237A US3420237A US576944A US3420237DA US3420237A US 3420237 A US3420237 A US 3420237A US 576944 A US576944 A US 576944A US 3420237D A US3420237D A US 3420237DA US 3420237 A US3420237 A US 3420237A
- Authority
- US
- United States
- Prior art keywords
- tape
- sleeve
- gauze
- packing
- nasal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 238000000034 method Methods 0.000 title claims description 28
- 208000001780 epistaxis Diseases 0.000 title claims description 24
- 239000000463 material Substances 0.000 claims description 46
- 238000012856 packing Methods 0.000 claims description 26
- 238000003780 insertion Methods 0.000 claims description 5
- 230000037431 insertion Effects 0.000 claims description 5
- 239000003814 drug Substances 0.000 description 6
- 230000002439 hemostatic effect Effects 0.000 description 6
- 239000004033 plastic Substances 0.000 description 6
- 229920003023 plastic Polymers 0.000 description 6
- 230000003115 biocidal effect Effects 0.000 description 5
- 229920003051 synthetic elastomer Polymers 0.000 description 5
- 239000005061 synthetic rubber Substances 0.000 description 5
- 239000004744 fabric Substances 0.000 description 4
- 229920003052 natural elastomer Polymers 0.000 description 4
- 229920001194 natural rubber Polymers 0.000 description 4
- 239000002674 ointment Substances 0.000 description 4
- 210000000492 nasalseptum Anatomy 0.000 description 3
- 210000003800 pharynx Anatomy 0.000 description 3
- 206010030113 Oedema Diseases 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 229920001971 elastomer Polymers 0.000 description 2
- 210000001331 nose Anatomy 0.000 description 2
- -1 polyethylene Polymers 0.000 description 2
- 239000005060 rubber Substances 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- UCTWMZQNUQWSLP-VIFPVBQESA-N (R)-adrenaline Chemical compound CNC[C@H](O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-VIFPVBQESA-N 0.000 description 1
- 229930182837 (R)-adrenaline Natural products 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 108010049003 Fibrinogen Proteins 0.000 description 1
- 102000008946 Fibrinogen Human genes 0.000 description 1
- 208000034693 Laceration Diseases 0.000 description 1
- 206010031252 Osteomyelitis Diseases 0.000 description 1
- 208000005141 Otitis Diseases 0.000 description 1
- 206010033078 Otitis media Diseases 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 108090000190 Thrombin Proteins 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- KIPLYOUQVMMOHB-MXWBXKMOSA-L [Ca++].CN(C)[C@H]1[C@@H]2[C@@H](O)[C@H]3C(=C([O-])[C@]2(O)C(=O)C(C(N)=O)=C1O)C(=O)c1c(O)cccc1[C@@]3(C)O.CN(C)[C@H]1[C@@H]2[C@@H](O)[C@H]3C(=C([O-])[C@]2(O)C(=O)C(C(N)=O)=C1O)C(=O)c1c(O)cccc1[C@@]3(C)O Chemical compound [Ca++].CN(C)[C@H]1[C@@H]2[C@@H](O)[C@H]3C(=C([O-])[C@]2(O)C(=O)C(C(N)=O)=C1O)C(=O)c1c(O)cccc1[C@@]3(C)O.CN(C)[C@H]1[C@@H]2[C@@H](O)[C@H]3C(=C([O-])[C@]2(O)C(=O)C(C(N)=O)=C1O)C(=O)c1c(O)cccc1[C@@]3(C)O KIPLYOUQVMMOHB-MXWBXKMOSA-L 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- CYDMQBQPVICBEU-UHFFFAOYSA-N chlorotetracycline Natural products C1=CC(Cl)=C2C(O)(C)C3CC4C(N(C)C)C(O)=C(C(N)=O)C(=O)C4(O)C(O)=C3C(=O)C2=C1O CYDMQBQPVICBEU-UHFFFAOYSA-N 0.000 description 1
- CYDMQBQPVICBEU-XRNKAMNCSA-N chlortetracycline Chemical compound C1=CC(Cl)=C2[C@](O)(C)[C@H]3C[C@H]4[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]4(O)C(O)=C3C(=O)C2=C1O CYDMQBQPVICBEU-XRNKAMNCSA-N 0.000 description 1
- 229960004475 chlortetracycline Drugs 0.000 description 1
- 235000019365 chlortetracycline Nutrition 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 208000019258 ear infection Diseases 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 229960005139 epinephrine Drugs 0.000 description 1
- 229940012952 fibrinogen Drugs 0.000 description 1
- 229920002457 flexible plastic Polymers 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 210000000867 larynx Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 210000003928 nasal cavity Anatomy 0.000 description 1
- 231100000344 non-irritating Toxicity 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 210000001584 soft palate Anatomy 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 229940063650 terramycin Drugs 0.000 description 1
- SRVJKTDHMYAMHA-WUXMJOGZSA-N thioacetazone Chemical compound CC(=O)NC1=CC=C(\C=N\NC(N)=S)C=C1 SRVJKTDHMYAMHA-WUXMJOGZSA-N 0.000 description 1
- 229960004072 thrombin Drugs 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/12—Surgical instruments, devices or methods for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels or umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12131—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/12—Surgical instruments, devices or methods for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels or umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/12—Surgical instruments, devices or methods for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels or umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12099—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/24—Surgical instruments, devices or methods for use in the oral cavity, larynx, bronchial passages or nose; Tongue scrapers
Definitions
- the present invention relates to a novel article and process for the treatment of severe nosebleed, i.e., severe epistaxis, and, more particularly, to a method and article for treating such severe epistaxis which employs a thin tape of rubberized material surrounded by a sleeve of gauze.
- postnasal packs are often applied improperly. When so applied, they may cause edema and pain, or their effects may be even more serious, such as osteomyelitis of the base of the sphenoid, ear infection, and so much edema that tracheostomy is necessary.
- Other complications include hemotympanurn, with or without otitis media, and lacerations of the soft palate and floor of the nose.
- a further object of the present invention is to provide a process for the treatment of severe epistaxis which is easily and practically performed, and which eliminates the inherent deficiencies and disadvantages of prior known proceses, especially conventional posterior packing.
- a still further object of the present invention is to provide an article which comprises a thin, flexible tape of Claims rubberized material surrounded by a sleeve of gamelike material, which article can be employed to easily and practically treat severe epistaxis by the process of the present invention.
- a yet further object of the present invention is to provide such a process for the treatment of severe epistaxis wherein a thin, flexible, rubberized tape surrounded by a sleeve of gauze-like material is drawn through the nasal passages to form a firm wall across the posterior chamber and to provide packing of the nasal passages.
- FIGURE 1 is a view in elevation showing the tape of the present invention.
- FIGU-R-ES 2 to 7 are frontal views pictorially showing various stages of the process of the present invention.
- the armored tape of the present invention which is employed in the treatment of severe epistaxis, comprises, in combination, two parts.
- the inner portion or tape 2 comprises a thin, flexible, rubberized material.
- This can be either a natural or a synthetic rubber, or a flexible plastic material (i.e., polyethylene, etc.), or a fabric matrix which is impregnated with a natural or synthetic rubber or plastic.
- the only essential characteristic of such material is that it be sufficiently flexible so as to be able to conform itself to the contour of the nasal passage and have suflicient density so as to form a firm Wall across the posterior chamber of the nasal passages so as to prevent the how of blood.
- the rubberized tape 2 is in the order of one-half inch to one inch in width, although narrower or wider strips can be advantageously employed where desired, or necessary for particular patients, or appropriate medical situations.
- a sleeve 4 of gauze-like material Surrounding the tape 2 of the article of the present invention, is a sleeve 4 of gauze-like material.
- gauzelike material of the sleeve 4 surrounding the tape 2 can be any conventionally-employed gauze-like material used for medical purposes. Exemplary are the cotton and gauze materials. This gauze-like material should be soft and non-irritating to the walls of the nasal passages.
- the sleeve 4 of gauze-like material additionally can act as a carrier for a hemostatic medicament, etc. Therefore, the gauze-like sleeve 4 may be impregnated or coated with a suitable antibiotic ointment, hemostatic medicament, astringent, etc. Exemplary materials include commercial preparations of penicillin, streptomycin, aureomycin, terramycin, thrombin, fibrinogen, epinephrine, etc.
- FIGURE 2 shows the insertion of the tape and sleeve of the present invention in the nasal passages.
- a conventional nasal catheter 6 is utilized to draw the rubberized tape-gauze-like sleeve assemblage through the mouth and down through the nostrils of the patient, the catheter having been inserted through the nostrils of the patient.
- the treatment is started by first cleaning the nose of the patient and applying an aneestetic, if necessary.
- a rubber or plastic catheter 6 with a slit near its tip is passed through the nasal chamber and grasped as it appears in the pharynx.
- the rubberized tape and surrounding sleeve is now inserted and passed through the slit in the catheter.
- the catheter is then pulled back through the nasal passage leaving the tape and surrounding sleeve in place extending about eight inches from the nostril.
- the rubber or plastic catheter 6 is then inserted through the second notril in a similar manner.
- the other end of the tape and surrounding sleeve is thereafter inserted into the catheter as shown in FIGURE 3, and the catheter is again pulled back through the nasal passage with the attached tape and surrounding sleeve.
- the tape and surrounding sleeve when removed from the catheter, now has an end extending from each nostril of the patient. This position is represented in FIGURE 4. At this point, the tape and surrounding sleeve form a firm wall across the posterior chamber of the nasal passages.
- the two ends of the tape and surrounding sleeve which extend from the nostrils of the patient are now anchored with forceps 8, as illustrated in FIG- URES 5 and 6.
- the packing of the nostrils of the patient may then proceed by pushing back the gauze from the tape little by little i.e., in increments, as shown in FIG- URE 6 by use of a conventional packing instrument 10.
- additional packing material may be utilized.
- additional packing can comprise any suitable medical packing material conventionally used for packing of wounds.
- the gauze-like sleeve acts as sufiicient packing material.
- a gauze pad may be advantageously inserted in place in front of the nasal septum to act as a base for the subsequent tying of the ends of the tape and surrounding sleeve.
- the employment of the sleeve of gauze material surrounding the rubberized tape serves a dual function-that of allowing the production of a more firm wall across the posterior chamber of the nasal passages, and that of simultaneously supplying antibiotic, hemostatic medicament, or astringent, to the treatment area.
- An article for the treatment of severe epistaxis which comprises a flexible thin tape of rubberized material surrounded by a sleeve of gauze-like material.
- a method of treating severe epistaxis which comprises (1) inserting a flexible thin tape of rubberized material surrounded by a sleeve of gauze-like material through the nasal passages by means of a nasal catheter, said tape and sleeve, after insertion, having an end thereof extending from each nostril, said tape and surrounding sleeve forming a firm wall across the posterior chamber of the nasal passages, (2) packing the nostrils by feeding in gauze in increments, and (3) closing off the nostrils by means of the ends of said tape and surrounding sleeve extending therefrom.
- the rubberized material is selected from natural and synthetic rubber, plastics, and cloth matrices impregnated with such materials.
- the rubberized material is selected from natural and synthetic rubber, plastics, and cloth matrices impregnated with such materials.
Landscapes
- Health & Medical Sciences (AREA)
- Surgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Vascular Medicine (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Reproductive Health (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Materials For Medical Uses (AREA)
Description
J 7, 1969 s. o. FORITAY 3,420,231
PROCESS AND ARTICLE FOR THE TREATMENT OF SEVERE EPISTAXIS Filed Sept. 2, 1966 i 5 l f INVENTOR STEVEN A. FORTAY ATTORNEYS United States Patent Ofiflce 3,420,237 Patented Jan. 7, 1969 3,420,237 PROCESS AND ARTICLE FOR THE TREATMENT OF SEVERE EPISTAXIS Steven 0. Fortay, Woodbridge, N.J.; Martha K. Fortay,
executrix of the estate of said Steven 0. Fortay, (leceased; assignor to Martha K. Fortay (widow of Steven 0. Fortay), Woodbridge Township, NJ.
Filed Sept. 2, 1966, Ser. No. 576,944
U.S. Cl. 128325 Int. Cl. A61h 17/12 The present invention relates to a novel article and process for the treatment of severe nosebleed, i.e., severe epistaxis, and, more particularly, to a method and article for treating such severe epistaxis which employs a thin tape of rubberized material surrounded by a sleeve of gauze.
More than a century ago, a method of treating severe nosebleed by posterior packing was introduced. This method of packing the posterior chamber of the nasal passage has many shortcomings, however. First of all, it is a quite involved and delicate process to manipulate the medical packing material into the posterior chamber of the nasal passages in order to adequately pack this posterior region to supply adequate pressure so as to relieve and eliminate the problem of a severe nosebleed. Furthermore, the packing of the posterior chamber of the nasal passage is fraught with the disadvantage that the packing material easily slips from its intended area, blocking the larynx and throat opening of the patient.
In addition, postnasal packs are often applied improperly. When so applied, they may cause edema and pain, or their effects may be even more serious, such as osteomyelitis of the base of the sphenoid, ear infection, and so much edema that tracheostomy is necessary. Other complications include hemotympanurn, with or without otitis media, and lacerations of the soft palate and floor of the nose.
Although there have been various attempts made and ideas suggested for a method to employ as a quick and practical alternative to conventional posterior packing none of these have been satisfactorily adapted for the treatment of severe epistaxis. Such concepts involve both physical and chemical approaches to this problem. Such alternative procedures usually involve the employment of complicated equipment and/ or processes in which a great deal of assistance is necessary to treat the severe nosebleed. Note U.S. Patent 2,647,515. Thus, until the present invention, there has not been provided a simple and practical alternative to the treatment of severe nosebleed by posterior packing. By the present invention, however, it has now been found possible to treat a severe epistaxis in a simple and practical manner without the use of complicated devices and without the necessity for assistants. It has now been found possible to treat severe nosebleed by the use of a thin tape of rubberized material having a sleeve of gauze-like material surrounding such tape, which tape and surrounding sleeve form a firm wall across the posterior chamber of the nasal passage.
This is accomplished by drawing such tape and surrounding armored sleeve through the nasal passages by the use of a conventional nasal catheter.
It is, therefore, a principal object of the present invention to provide an article for the treatment of severe nosebleed which is free from the inherent deficiencies of previously-employed materials and techniques.
A further object of the present invention is to provide a process for the treatment of severe epistaxis which is easily and practically performed, and which eliminates the inherent deficiencies and disadvantages of prior known proceses, especially conventional posterior packing.
A still further object of the present invention is to provide an article which comprises a thin, flexible tape of Claims rubberized material surrounded by a sleeve of gamelike material, which article can be employed to easily and practically treat severe epistaxis by the process of the present invention.
A yet further object of the present invention is to provide such a process for the treatment of severe epistaxis wherein a thin, flexible, rubberized tape surrounded by a sleeve of gauze-like material is drawn through the nasal passages to form a firm wall across the posterior chamber and to provide packing of the nasal passages.
Still further objects and advantages of the process and article of the present invention will become more apparent from the following more detailed description of the present invention and the accompanying drawing, wherem:
FIGURE 1 is a view in elevation showing the tape of the present invention.
FIGU-R-ES 2 to 7 are frontal views pictorially showing various stages of the process of the present invention.
In the various figures, like numerals represent like elements.
As can be seen from FIGURE 1, the armored tape of the present invention, which is employed in the treatment of severe epistaxis, comprises, in combination, two parts. The inner portion or tape 2 comprises a thin, flexible, rubberized material. This can be either a natural or a synthetic rubber, or a flexible plastic material (i.e., polyethylene, etc.), or a fabric matrix which is impregnated with a natural or synthetic rubber or plastic. The only essential characteristic of such material is that it be sufficiently flexible so as to be able to conform itself to the contour of the nasal passage and have suflicient density so as to form a firm Wall across the posterior chamber of the nasal passages so as to prevent the how of blood.
Ordinarily, the rubberized tape 2 is in the order of one-half inch to one inch in width, although narrower or wider strips can be advantageously employed where desired, or necessary for particular patients, or appropriate medical situations.
Surrounding the tape 2 of the article of the present invention, is a sleeve 4 of gauze-like material. Such gauzelike material of the sleeve 4 surrounding the tape 2 can be any conventionally-employed gauze-like material used for medical purposes. Exemplary are the cotton and gauze materials. This gauze-like material should be soft and non-irritating to the walls of the nasal passages.
In addition to allowing the tape 2 to form a more firm wall across the posterior chamber of the nasal passages, the sleeve 4 of gauze-like material additionally can act as a carrier for a hemostatic medicament, etc. Therefore, the gauze-like sleeve 4 may be impregnated or coated with a suitable antibiotic ointment, hemostatic medicament, astringent, etc. Exemplary materials include commercial preparations of penicillin, streptomycin, aureomycin, terramycin, thrombin, fibrinogen, epinephrine, etc.
FIGURE 2 shows the insertion of the tape and sleeve of the present invention in the nasal passages. Thus, a conventional nasal catheter 6 is utilized to draw the rubberized tape-gauze-like sleeve assemblage through the mouth and down through the nostrils of the patient, the catheter having been inserted through the nostrils of the patient.
The treatment is started by first cleaning the nose of the patient and applying an aneestetic, if necessary. A rubber or plastic catheter 6 with a slit near its tip is passed through the nasal chamber and grasped as it appears in the pharynx. The rubberized tape and surrounding sleeve is now inserted and passed through the slit in the catheter.
3 This point in the process of the present inevntion is shown in FIGURE 2.
The catheter is then pulled back through the nasal passage leaving the tape and surrounding sleeve in place extending about eight inches from the nostril. The rubber or plastic catheter 6 is then inserted through the second notril in a similar manner. The other end of the tape and surrounding sleeve is thereafter inserted into the catheter as shown in FIGURE 3, and the catheter is again pulled back through the nasal passage with the attached tape and surrounding sleeve. The tape and surrounding sleeve, when removed from the catheter, now has an end extending from each nostril of the patient. This position is represented in FIGURE 4. At this point, the tape and surrounding sleeve form a firm wall across the posterior chamber of the nasal passages.
Advantageously, the two ends of the tape and surrounding sleeve which extend from the nostrils of the patient are now anchored with forceps 8, as illustrated in FIG- URES 5 and 6. The packing of the nostrils of the patient may then proceed by pushing back the gauze from the tape little by little i.e., in increments, as shown in FIG- URE 6 by use of a conventional packing instrument 10.
Optionally, after packing of the nasal passages by use of the sleeve of gauze-like material, additional packing material may be utilized. Such additional packing can comprise any suitable medical packing material conventionally used for packing of wounds. In most instances, however, the gauze-like sleeve acts as sufiicient packing material.
It is of note that because of the firm wall formed across the posterior chamber of the nasal passages by the tape and surrounding sleeve of the present invention, there is no fear of the packing material being inserted too far into the nasal cavity to cause blockage of the throat area.
Also, ease of removal of additional packing material is a distinct advantage of the process of the present invention since the tape and gauze-like sleeve acts as a barrier to the insertion of additional packing material to such a point at which its removal can no longer be accomplished with case. When both chambers are packaged, a gauze pad may be advantageously inserted in place in front of the nasal septum to act as a base for the subsequent tying of the ends of the tape and surrounding sleeve.
The ends of the tape and surrounding sleeve are tied across the pad in front of the nasal septum. At this point, the treatment is completed. This last step, or position, is shown in FIGURE 7.
As stated previously, the employment of the sleeve of gauze material surrounding the rubberized tape, serves a dual function-that of allowing the production of a more firm wall across the posterior chamber of the nasal passages, and that of simultaneously supplying antibiotic, hemostatic medicament, or astringent, to the treatment area.
It has been unexpectedly found that the use of a gauze sleeve in conjunction with the rubberized tape produces results far superior to those that could be achieved by the use of a rubberize dtape alone. In this connection, it has been found that the use of a rubberized tape alone in many instances does not satisfactorily form a firm wall across the posterior chamber of the nasal passages in that such material tends to slip and move from its intended point. In addition, employment of the gauze-like sleeve eliminates any possibility of irritation to the nasal passages which can be encountered by the use of a rubberized tape by itself.
While the present invention has beenprimarily described with respect to the treatment of severe epistaxis, that is, a severe nosebleed, it should be understood that this invention can be advantageously employed whenever nasal packing is required. Thus, the process and article of the present invention, with their accompanying advantages, can be utilized in packing of the nasal passages in case of nasal fractures, etc.
While a preferred embodiment of the present invention has been illustrated, it is to be understood that the present invention is in no way to be deemed as limited thereto, but should be construed as broadly as all equivalents thereof.
I claim:
1. An article for the treatment of severe epistaxis which comprises a flexible thin tape of rubberized material surrounded by a sleeve of gauze-like material.
2. The article of claim 1 wherein said sleeve of gauzelike material is coated or impregnated with antibiotic ointment or a hemostatic medicament.
3. The article of claim 1 wherein said rubberized material is selected from natural and synthetic rubbers, plastics, and cloth matrices impregnated with such materials.
4. A method of treating severe epistaxis which comprises (1) inserting a flexible thin tape of rubberized material surrounded by a sleeve of gauze-like material through the nasal passages by means of a nasal catheter, said tape and sleeve, after insertion, having an end thereof extending from each nostril, said tape and surrounding sleeve forming a firm wall across the posterior chamber of the nasal passages, (2) packing the nostrils by feeding in gauze in increments, and (3) closing off the nostrils by means of the ends of said tape and surrounding sleeve extending therefrom.
5. The method of claim 4 wherein a pad of gauze-like material is placed in front of the nasal septum as a base prior to scaling off the nostrils by the ends of the tape and surrounding sleeve extending therefrom.
6. The method of claim 4 wherein the sleeve of gauzelike material is coated or impregnated with an antibiotic ointment or hemostatic medicament.
7. The method of claim 4 wherein the rubberized material is selected from natural and synthetic rubber, plastics, and cloth matrices impregnated with such materials.
8. The method of claim 4 wherein the ends of the tape and surrounding sleeve are held with forceps to create an anchor after insertion of the tape and sleeve and prior to packing to facilitate packing of the nasal passages and to create a firm wall across the posterior chamber of the nasal passages.
9. The method of claim 8 wherein the sleeve of gauzelike material is coated or impregnated with an antibiotic ointment or hemostatic medicament.
10. The method of claim 8 wherein the rubberized material is selected from natural and synthetic rubber, plastics, and cloth matrices impregnated with such materials.
References Cited UNITED STATES PATENTS 2,007,503 7/1935 Riordan 128-296 2,154,968 4/1939 Alkio 128348 2,524,195 10/1950 Hoover 128325 2,647,515 8/1953 Pollock et al. 128-325 2,847,997 8/1958 Tibone 128325 3,049,125 8/1962 Kriwkowitsch 128325 CHARLES F. ROSENBAUM, Primary Examiner.
Claims (2)
1. AN ARTICLE FOR THE TREATMENT OF SEVERE EPISTAXIS WHICH COMPRISES A FLEXIBLE THIN TAPE OF RUBBERIZED MATERIAL SURROUNDED BY A SLEEVE OF GAUZE-LIKE MATERIAL.
4. A METHOD OF TREATING SEVERE EPISTAXIS WHICH COMPRISES (1) INSERTING A FLEXIBLE THIN TAPE OF RUBBERIZED MATERIAL SURROUNDED BY SLEEVE OF GAUZE-LIKE MATERIAL THROUGH THE NASAL PASSAGES BY MEANS OF A NASAL CATHETER, SAID TABE AND SLEEVE, AFTER INSERTION, HAVING AND END THEREOF EXTENDING FROM EACH NOSTRIL, SAID TAPE AND SURROUNDING SLEEVE FORMING A FIRM WALL ACROSS THE POSTERIOR CHAMBER OF THE NASAL PASSAGES, (2) PACKING THE NOSTRILS BY FEEDING IN GAUZE IN INCREMENTS, AND (3) CLOSING OFF THE NOSTRILS BY MEANS OF THE ENDS OF SAID TAPE AND SURROUNDING SLEEVE EXTENDING THEREFROM.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US57694466A | 1966-09-02 | 1966-09-02 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| US3420237A true US3420237A (en) | 1969-01-07 |
Family
ID=24306645
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US576944A Expired - Lifetime US3420237A (en) | 1966-09-02 | 1966-09-02 | Process and article for the treatment of severe epistaxis |
Country Status (1)
| Country | Link |
|---|---|
| US (1) | US3420237A (en) |
Cited By (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4338941A (en) * | 1980-09-10 | 1982-07-13 | Payton Hugh W | Apparatus for arresting posterior nosebleeds |
| US4820266A (en) * | 1986-01-27 | 1989-04-11 | Berry Yale J | Method of stopping nose bleeds |
| US4883465A (en) * | 1988-05-24 | 1989-11-28 | Brennan H George | Nasal tampon and method for using |
| US5011474A (en) * | 1988-05-24 | 1991-04-30 | Brennan H George | Methods for controlling nasal hemorrhaging |
| US6306154B1 (en) * | 1997-06-18 | 2001-10-23 | Bhk Holding | Hemostatic system for body cavities |
| US20030105483A1 (en) * | 2000-05-09 | 2003-06-05 | Hudson John Overton | Nasal packing device |
| US6620132B1 (en) | 1996-01-11 | 2003-09-16 | Joseph I. Skow | Surgical irrigation device |
| US20040073299A1 (en) * | 2000-12-16 | 2004-04-15 | Hudson John Overton | Hemostatic device |
| NL1024218C2 (en) * | 2003-09-03 | 2005-03-07 | Stichting Sint Annadal | Device for treating fistulas. |
| US20050175580A1 (en) * | 2001-01-05 | 2005-08-11 | Daniela Salvemini | Compositions and methods for enhancing cytokine activity and treating hypotension associated with the administration of cytokines |
| US20050236001A1 (en) * | 2004-04-27 | 2005-10-27 | Applied Medical Technology, Inc. | Bridle catheter with umbilical tape |
| US7018392B2 (en) | 1998-04-08 | 2006-03-28 | Arthrocare Corporation | Hemostatic system for body cavities |
| US7799048B2 (en) | 2000-05-09 | 2010-09-21 | Arthrocare Corporation | Nasal packing device |
| US20130338521A1 (en) * | 2012-06-18 | 2013-12-19 | Matthew Thompson | Nasal tube device and method |
| US9789272B2 (en) | 2012-08-10 | 2017-10-17 | Applied Medical Technology, Inc. | Bridle device and method |
| US10314994B2 (en) | 2013-12-10 | 2019-06-11 | Applied Medical Technology, Inc. | Bridle catheter |
| US10806476B2 (en) | 2017-11-12 | 2020-10-20 | David Awrey Randall | Anterior—posterior inflatable nosebleed packing |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2007503A (en) * | 1933-01-26 | 1935-07-09 | Howard C Riordan | Nasal pack |
| US2154968A (en) * | 1935-12-23 | 1939-04-18 | Alkio Viljo Verner | Process and apparatus for treatment of diseased obstruction of the lacrymal ducts |
| US2524195A (en) * | 1950-04-13 | 1950-10-03 | John R C Hoover | Gauze packing instrument |
| US2647515A (en) * | 1951-08-20 | 1953-08-04 | Professional Supply Inc | Inflatable dam for arresting bleeding in the internal body cavities |
| US2847997A (en) * | 1956-01-13 | 1958-08-19 | James J Tibone | Catheter |
| US3049125A (en) * | 1960-03-28 | 1962-08-14 | Kriwkowitsch George | Nose packing device |
-
1966
- 1966-09-02 US US576944A patent/US3420237A/en not_active Expired - Lifetime
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2007503A (en) * | 1933-01-26 | 1935-07-09 | Howard C Riordan | Nasal pack |
| US2154968A (en) * | 1935-12-23 | 1939-04-18 | Alkio Viljo Verner | Process and apparatus for treatment of diseased obstruction of the lacrymal ducts |
| US2524195A (en) * | 1950-04-13 | 1950-10-03 | John R C Hoover | Gauze packing instrument |
| US2647515A (en) * | 1951-08-20 | 1953-08-04 | Professional Supply Inc | Inflatable dam for arresting bleeding in the internal body cavities |
| US2847997A (en) * | 1956-01-13 | 1958-08-19 | James J Tibone | Catheter |
| US3049125A (en) * | 1960-03-28 | 1962-08-14 | Kriwkowitsch George | Nose packing device |
Cited By (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4338941A (en) * | 1980-09-10 | 1982-07-13 | Payton Hugh W | Apparatus for arresting posterior nosebleeds |
| US4820266A (en) * | 1986-01-27 | 1989-04-11 | Berry Yale J | Method of stopping nose bleeds |
| US4883465A (en) * | 1988-05-24 | 1989-11-28 | Brennan H George | Nasal tampon and method for using |
| US5011474A (en) * | 1988-05-24 | 1991-04-30 | Brennan H George | Methods for controlling nasal hemorrhaging |
| US6620132B1 (en) | 1996-01-11 | 2003-09-16 | Joseph I. Skow | Surgical irrigation device |
| US6306154B1 (en) * | 1997-06-18 | 2001-10-23 | Bhk Holding | Hemostatic system for body cavities |
| US7018392B2 (en) | 1998-04-08 | 2006-03-28 | Arthrocare Corporation | Hemostatic system for body cavities |
| US20100324534A1 (en) * | 2000-05-09 | 2010-12-23 | Arthrocare Corporation | Nasal packing device |
| US20030105483A1 (en) * | 2000-05-09 | 2003-06-05 | Hudson John Overton | Nasal packing device |
| US8137375B2 (en) | 2000-05-09 | 2012-03-20 | Arthrocare Corporation | Nasal packing device |
| US7799048B2 (en) | 2000-05-09 | 2010-09-21 | Arthrocare Corporation | Nasal packing device |
| US20040073299A1 (en) * | 2000-12-16 | 2004-04-15 | Hudson John Overton | Hemostatic device |
| US20050175580A1 (en) * | 2001-01-05 | 2005-08-11 | Daniela Salvemini | Compositions and methods for enhancing cytokine activity and treating hypotension associated with the administration of cytokines |
| WO2005020823A1 (en) * | 2003-09-03 | 2005-03-10 | Stichting Sint Annadal | Device for treating fistulas |
| NL1024218C2 (en) * | 2003-09-03 | 2005-03-07 | Stichting Sint Annadal | Device for treating fistulas. |
| US20050236001A1 (en) * | 2004-04-27 | 2005-10-27 | Applied Medical Technology, Inc. | Bridle catheter with umbilical tape |
| US7534228B2 (en) * | 2004-04-27 | 2009-05-19 | Applied Medical Technology, Inc. | Bridle catheter with umbilical tape |
| US20130338521A1 (en) * | 2012-06-18 | 2013-12-19 | Matthew Thompson | Nasal tube device and method |
| US10426941B2 (en) * | 2012-06-18 | 2019-10-01 | Applied Medical Technology, Inc. | Nasal tube device and method |
| US9789272B2 (en) | 2012-08-10 | 2017-10-17 | Applied Medical Technology, Inc. | Bridle device and method |
| US10314994B2 (en) | 2013-12-10 | 2019-06-11 | Applied Medical Technology, Inc. | Bridle catheter |
| US10806476B2 (en) | 2017-11-12 | 2020-10-20 | David Awrey Randall | Anterior—posterior inflatable nosebleed packing |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5827224A (en) | Pressure applying fluid transfer medical device | |
| US4338941A (en) | Apparatus for arresting posterior nosebleeds | |
| US2847997A (en) | Catheter | |
| US7487779B2 (en) | Cover and applicator for a portion of a mammalian body | |
| US2513014A (en) | Apparatus for implanting medicinal pellets subcutaneously | |
| US5713855A (en) | Pressure applying fluid transfer medical method | |
| US1926900A (en) | Catamenial device | |
| JPH01259860A (en) | Bandage holder | |
| CN111698976B (en) | ear tube | |
| SE337888B (en) | ||
| US2687729A (en) | Medical appliance | |
| US1575123A (en) | Medical appliance | |
| US2601851A (en) | Applicator for treating skin ailments | |
| US2877767A (en) | Support for tampons | |
| US3886940A (en) | Capsule | |
| US3481335A (en) | Vaginal tampon | |
| US3664341A (en) | Vaginal capsule | |
| KUHN et al. | Complications of postnasal packing for epistaxis | |
| Conley | LVII The Use of Plastic Tubing in the Treatment of Chronic Maxillary Sinusitis | |
| Robb | LVI Laryngeal Stenosis | |
| CN108836592B (en) | Nipple invagination correction device | |
| RU15170U1 (en) | TAMPON | |
| RU2165751C1 (en) | Method for applying postoperative tamponade in performing operations on the middle ear | |
| Steinberg | A simplified technique for the surgery of ingrowing nails | |
| CN205411468U (en) | What postoperative used can place binder that helps ascites absorbent core |